MLAB 1227: C OAGULATION K ERI B ROPHY - M ARTINEZ Secondary Hemostasis Part Three.

Slides:



Advertisements
Similar presentations
Coagulation Or Clotting of Blood
Advertisements

Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis.
Haemostasis and NovoSeven®
Basic Principles of Hemostasis
Hemostasis: Dr.Faten Hemostasis: Hemo/Stasis Hemo=BleedigStasis=Stop.
Blood Clotting Robin Gray.
HEMOSTAZ Yard. Doç. Dr. Murat ÖRMEN. Vessels Platelets Fibrinolysis/Inhibitors Coagulation Proteins BleedingClotting Hemostaz.
MLAB 1227: Coagulation Keri Brophy-Martinez
MLAB Coagulation Keri Brophy-Martinez
Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Damaged Blood Vessels. On vessel injury
Blood Course By Dr. Khidir Abdel Galil.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Coagulation Cascade Ahmad Shihada Silmi Msc,FIBMS IUG Faculty of Science Medical Technology Dept.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
Hemostasis system. Hemostasis is the physiologic system, which support the blood in the fluid condition and prevent bloodless. Hemostasis is the physiologic.
Implant of a Medical Device and the Wound Healing Process.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
HEMOSTASIS Secondary hemostasis.
Physiology of haemostasis system
MLAB 1227: C OAGULATION K ERI B ROPHY -M ARTINEZ Overview of Hemostasis: Part Two.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
Protective functions of blood Hemostasis system
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
Blood Part 2. Hemostasis Responses that stop bleeding When blood vessels are damaged or ruptured, the hemostatic response must be quick, localized to.
Hemostasis Constriction of vessel Aggregation of platelets
Hemostasis & blood coagulation Dr. Wasif Haq. Hemostasis Hemostasis: prevention of blood loss. Is hemostasis same as homeostasis?
Coagulation Mechanisms
Curs an IV limba engleza
Hemostasis and blood coagulation Lecture by Dr Sandeep :30-10:30 am.
Blood – Part 3. Hemostasis  Hemostasis – Stoppage of blood flow.  If a blood vessel wall breaks a series of reactions is set in motion.  This response.
Clot Formation Review with Animations
Dr. S. Parthasarathy MD DA DNB PhD (physio) Mahatma Gandhi medical college and research institute, puducherry – India Prothrombin time.
Ahmad Sh. Silmi Msc, FIBMS IUG MT department Secondary Hemostasis Coagulation Factors.
Haemostasis Dr.Salah Elmalik Department of Physiology
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
HAEMOSTASIS & FIBRINOLYSIS
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
PHYSIOLOGIC CONTROL OF HEMOSTASIS MLAB Coagulation Keri Brophy-Martinez.
MLAB Coagulation Keri Brophy-Martinez Fibrinolytic System.
Coagulation and fibrinolysis
Hemodynamics 2.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
بسم الله الرحمن الرحيم.
Blood Clotting In the absence of blood vessel damage, platelets are repelled from each other and from the endothelium of blood vessels. When a blood vessel.
Blood Coagulation Dr Mahvash Khan MBBS, MPhil Hemostasis The third mechanism by which Hemostasis can be achieved is by formation of a blood clot.
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Blood coagulation. Blood coagulation Blood coagulation Conversion of fluid state of blood into semisolid state by activation and interaction of pro-coagulants.
Platelets (Thrombocytes)
MLAB Coagulation Keri Brophy-Martinez
Secondary Haemostasis
These factors prevent blood clotting - in normal state.
2nd Year Medicine- Blood Module May 2008
General Principles of Hemostasis Kristine Krafts, M.D.
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Steps in clotting mechanism
Implant of a Medical Device and the Wound Healing Process.
UNIT 3 NOTES: Hematopoiesis & Hemostasis
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
General Principles of Hemostasis Kristine Krafts, M.D.
Coagulation.
Presentation transcript:

MLAB 1227: C OAGULATION K ERI B ROPHY - M ARTINEZ Secondary Hemostasis Part Three

E XTRINSIC P ATHWAY A CTIVATION 1. Cell injury releases TF into vasculature ▫ TF provides the phospholipid component where the coagulation factors interact 2. TF complexes with Ca ++ and VIIa to activate X

E XTRINSIC P ATHWAY : C OAGULATION F ACTORS Factor III: Tissue Thromboplastin/Tissue Factor (TF) Manufactured in most body tissues – especially lungs, brain, placenta, RBC membranes. Does not circulate unless damage occurs to tissues Purpose : Attracts calcium ions to help the formation of procoagulant enzyme complexes. Converts prothrombin to thrombin

E XTRINSIC P ATHWAY : C OAGULATION F ACTORS Factor VII – Proconvertin (Stabile Factor) Produced in liver Vitamin K dependent Is especially sensitive to Coumadin anticoagulant therapy Purpose Activated by tissue thromboplastin(TF)

E XTRINSIC P ATHWAY Monitored by the Protime (PT) test Monitors oral coagulation therapy such as coumadin, coumarin Detects abnormalities in Factor VII, exclusively, but can also pick up deficiencies in the common pathway

C OMMON P ATHWAY Activation of either or both pathways results in the conversion of factor X to Xa In the common pathway all prothrombin is converted to thrombin, which in turn is converted to fibrin on the phospholipid surface at the site of injury.

C OMMON P ATHWAY Thrombin – enzyme not normally present in plasma. Converts fibrinogen (I) to fibrin (Ia) Causes potent platelet aggregation Aids in stabilizing fibrin clot by activating Factor XIII Activates Protein C to control the extent of clotting Suppress fibrinolysis

C OMMON P ATHWAY : C OAGULATION F ACTORS Factor X – Stuart Factor (Stuart-Prower) Produced in liver Vitamin K dependent Activated form acts with V, Ca ++ and PF 3 to form active thromboplastin

C OMMON P ATHWAY : C OAGULATION F ACTORS Factor V: Proaccelerin (Labile Factor) Produced in liver Deteriorates rapidly in room temperature Purpose Essential in thromboplastin formation Increased in pregnancy & inflammation Consumed during coagulation, not found in serum

C OMMON P ATHWAY : C OAGULATION F ACTORS Factor II: Prothrombin Manufactured in the liver Vitamin K dependent Purpose Upon exposure to V, Xa, PF 3 and Ca ++, it is converted to thrombin Stimulates platelet aggregation in presence of Ca ++

C OMMON P ATHWAY : F ORMATION OF F IBRIN Thrombin acts upon fibrinogen (Factor I) to form fibrin (Ia) Fibrin clot is stabilized by Factor XIII by crosslinking the fibrin polymers

C OMMON P ATHWAY : C OAGULATION F ACTORS Factor I: Fibrinogen MW = 341,000 Normal value in plasma mg/dl Manufactured in the liver Absent in serum Purpose Upon exposure to thrombin, forms fibrin

C OMMON P ATHWAY : C OAGULATION F ACTORS Factor XIII – Fibrin Stabilizing Factor Produced in liver and platelets Necessary to form a stable clot – causes a crosslinking of fibrin monomers

M ISC : C OAGULATION F ACTORS Factor IV: Calcium Obtained through diet and bone storage Needed in intrinsic and extrinsic pathways Removed by citrate Purpose Acts as a cofactor in many reactions of the coagulation cascade Needed for binding to the phospholipid surface, proper platelet function, XIII activation

M ISC : C OAGULATION F ACTORS There is no Factor VI

M ISC. All enzymatic reactions require a phospholipid surface, either supplied by the membranes of activated platelets (PF 3 ) or damaged tissues (TF). This phospholipid requirement limits coagulation reactions to the site and prevents clotting.

HELP!!! H OW W ILL I E VER G ET T HIS D OWN …. 1. Simplified enzymatic coagulation event VIII V XII ----XI---IX------X II IIa I VII

N EXT STEPS … 1. Change the sequence to Arabic numerals —11—9—10—2—T –1 7 **”T”= thrombin

L EARNING THE PT/PTT P ATHWAYS —11—9—10—2—T –1 7 **”T”= thrombin PT PTT

V ITAMIN K D EPENDANT F ACTORS C s s —11—9—10—2—T –1 7 ** Think of the central core for those requiring Vitamin K. Protein C and S also require Vitamin K. Protein C inhibits factors 8 and 5. Indicated by “X”

E XTENDED C OAGULATION SEQUENCE —11—9—10—2—T –1 7 13

M ISC —11—9—10—2—T – Thrombin sensitive factors Factors destroyed by plasmin Factors found in platelets

R EFERENCES McKenzie, Shirlyn B., and J. Lynne. Williams. "Chapter 30." Clinical Laboratory Hematology. Boston: Pearson, Print.